-
Featured Authors
-
Archives
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Latest From Biotech Now
Increasing Partnering at BIO
Mike May from Biotech Tallies writes: At the 2011 BIO International Convention, the number of one-on-one partnering meetings soared to 21,183… The increasing number of such meetings probably reflects the growth in biotechnology, the escalating importance of BIO’s annual meeting and the expanding need to partner for success in this field.
If Politics Trumps Science, Businesses Will Leave the U.S.
The Anchorage Daily News ran an editorial authored by California Farmer and Alaska fisherman Ted Sheely about the still-pending approval of the genetically engineered salmon. Sheely says some politicians in Washington think they have identified a threat to the pristine Alaska wilderness. These members of Congress are trying to force the federal government to slow down or stop a technology company that has figured out a way to make salmon less expensive for ordinary consumers. If they Read More >
National Academies Rehashes Controversies Over RFS
The National Academies this week released a Congressionally mandated study estimating the potential economic and environmental effects of producing the 36 billion gallons of biofuels required under the Renewable Fuel Standard. The conclusions of the report are 1) that cellulosic biofuels are highly unlikely to meet their mandate of 16 billion gallons by 2022 and 2) biofuels overall are unlikely to reduce greenhouse gas emissions by as much as required. Because the report stopped short Read More >
Incentivizing Biotech Growth; States and Regions Look to Stand Out from the Crowd
The United States’ prolonged economic woes have drastically impacted state budgets, causing across-the-board program cuts and reassessment of priorities. The bioscience industry was not immune to the crisis, but did begin to rebound much faster than many other industries. Because the biosciences remain a source of high-wage, high-skill jobs, almost every state in the country is actively engaged in building fundamental industry infrastructure. State-sponsored programs to encourage investment and help bioscience companies leverage existing resources Read More >
Policies that Benefit Start-Ups Grow the Bio-Economy
The United States remains the land of entrepreneurialism despite our lingering economic troubles. To maintain our nation’s global leadership and drive job growth, we must continue to create policies that encourage and reward innovation in growth industries — including biotechnology. Jeffrey Bussgang, a general partner at the venture capital firm Flybridge Capital Partners contributed an interesting piece to Fortune/CNN Money in which he points out that start-up companies – not small businesses – are the Read More >
